Aulis Capital published research showing that researchers developed a diagnostic approach skipping culturing blood bacteria using microfluidic chips and deep-learning image analysis.
Public source
Publisher name
Public post
Sepsis is a leading cause of death worldwide, and every hour of delay in starting the right antibiotic raises mortality risk. Yet the standard method for identifying the…
Company
Aulis Capital
Transforming Life for All
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 11–50 employees
About Aulis Capital
Aulis Capital is a global investment firm focusing on the health care industry. We partner with early and growth stage companies, leveraging scientific, analytical and investment expertise to accelerate innovations that improve patient care and advance medical technology. Contact: info@auliscapital.com
See moreLatest activity
Latest activity from Aulis Capital
3 signals
Research & Knowledge
Aulis Capital reported that a new oral drug, daraxonrasib, nearly doubled survival for patients with advanced, previously treated pancreatic cancer in a Phase 3 trial spanning 59 centers worldwide.
Presence & Recognition
Aulis Capital's Venture Partner Paul Li joined the panel discussion titled From Series A to IPO: Navigating the Asian Capital Stack at MedTech World Asia.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Leonis Capital
Leonis Capital published research by Jenny Xiao Liang Wu and Jay Zhao on 119 neolabs, gathering data and segmenting them based on capital requirements and revenue generation speed.
Research & Knowledge
Averin Capital
Averin Capital featured Thierry Bernard and his partner David Berry in an Averin Insights fireside chat discussing the future of diagnostics and the challenges hospitals face.
Research & Knowledge
Medical Supply Company (MSC)
Medical Supply Company (MSC) published research selection examining faster detection of candida auris colonisation.
Research & Knowledge
Grishin Robotics
Grishin Robotics published a study demonstrating a lab prototype of a magnetic millirobot developed by City University of Hong Kong in 2018.
Research & Knowledge
Healthy.Capital